论文部分内容阅读
胰岛素样生长因子－１进行Ⅱ期临床试验目前，塞法隆公司向ＦＤＡ提出申请：请求批准其用于脊髓灰质炎后遗症（ＰＰＳ）的肌营养剂（胰岛素样生长因子－１进行Ⅱ期临床试验。该公司声称他们计划在这方面进行四个试验。脊髓灰质炎后遗症是曾患过脊髓灰质炎的一些病人外周神...
Phase II Clinical Trial of Insulin-like Growth Factor-1 Currently, Cefaluil filed an application with the FDA for a request for approval of its nutrient supplement for poliomyelitis sequelae (PPS) (Insulin-like growth factor-1 for Phase II clinical trials The company claims they plan to conduct four trials in this area. Poliomyelitis sequelae are the peripheral nerves of some patients who have had poliomyelitis ...